| Toward a more accurate estimate of the prevalence of hepatitis C in the United States BR Edlin, BJ Eckhardt, MA Shu, SD Holmberg, T Swan Hepatology 62 (5), 1353-1363, 2015 | 514 | 2015 |
| Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial CR Wolfe, KM Tomashek, TF Patterson, CA Gomez, VC Marconi, MK Jain, ... The lancet respiratory medicine 10 (9), 888-899, 2022 | 136 | 2022 |
| Glycated Hemoglobin A1c as Screening for Diabetes Mellitus in HIV-Infected Individuals BJ Eckhardt, RS Holzman, CK Kwan, J Baghdadi, JA Aberg AIDS patient care and STDs 26 (4), 197-201, 2012 | 105 | 2012 |
| Risk factors for hepatitis C seropositivity among young people who inject drugs in New York City: Implications for prevention B Eckhardt, ER Winkelstein, MA Shu, MR Carden, C McKnight, ... PLoS One 12 (5), e0177341, 2017 | 70 | 2017 |
| Accessible hepatitis C care for people who inject drugs: a randomized clinical trial B Eckhardt, P Mateu-Gelabert, Y Aponte-Melendez, C Fong, S Kapadia, ... JAMA Internal Medicine 182 (5), 494-502, 2022 | 68 | 2022 |
| The impact of COVID-19 on people who inject drugs in New York City: increased risk and decreased access to services Y Aponte-Melendez, P Mateu-Gelabert, C Fong, B Eckhardt, S Kapadia, ... Harm reduction journal 18 (1), 118, 2021 | 67 | 2021 |
| Hepatitis C treatment outcomes for people who inject drugs treated in an accessible care program located at a syringe service program BJ Eckhardt, M Scherer, E Winkelstein, K Marks, BR Edlin Open forum infectious diseases 5 (4), ofy048, 2018 | 64 | 2018 |
| Linkage to hepatitis C care after incarceration in jail: a prospective, single arm clinical trial MJ Akiyama, D Columbus, R MacDonald, AO Jordan, J Schwartz, ... BMC Infectious Diseases 19 (1), 703, 2019 | 63 | 2019 |
| Comorbidity and clinical factors associated with COVID-19 critical illness and mortality at a large public hospital in New York City in the early phase of the pandemic (March … TD Filardo, MR Khan, N Krawczyk, H Galitzer, S Karmen-Tuohy, M Coffee, ... PloS one 15 (11), e0242760, 2020 | 59 | 2020 |
| Medical provider stigma experienced by people who use drugs (MPS-PWUD): development and validation of a scale among people who currently inject drugs in New York City C Fong, P Mateu-Gelabert, C Ciervo, B Eckhardt, Y Aponte-Melendez, ... Drug and alcohol dependence 221, 108589, 2021 | 45 | 2021 |
| Severe bacterial infections in people who inject drugs: the role of injection-related tissue damage A Hrycko, P Mateu-Gelabert, C Ciervo, R Linn-Walton, B Eckhardt Harm Reduction Journal 19 (1), 41, 2022 | 43 | 2022 |
| Hyperparathyroidism and complications associated with vitamin D deficiency in HIV-infected adults in New York City, New York CK Kwan, B Eckhardt, J Baghdadi, JA Aberg AIDS research and human retroviruses 28 (9), 1025-1032, 2012 | 41 | 2012 |
| Drugs for HIV infection BJ Eckhardt, RM Gulick Infectious diseases, 1293-1308. e2, 2017 | 39 | 2017 |
| Clinical and demographic factors associated with COVID-19, severe COVID-19, and SARS-CoV-2 infection in adults: a secondary cross-protocol analysis of 4 randomized clinical trials DA Theodore, AR Branche, L Zhang, DS Graciaa, M Choudhary, ... JAMA network open 6 (7), e2323349-e2323349, 2023 | 29 | 2023 |
| Hepatitis C virus risk among young people who inject drugs P Mateu-Gelabert, NS Sabounchi, H Guarino, C Ciervo, K Joseph, ... Frontiers in Public Health 10, 835836, 2022 | 27 | 2022 |
| Contact tracing for hepatitis C: The case for novel screening strategies as we strive for viral elimination C Katzman, P Mateu-Gelabert, SN Kapadia, BJ Eckhardt International Journal of Drug Policy 72, 33-39, 2019 | 26 | 2019 |
| Risk of COVID-19 after natural infection or vaccination AM Rick, MB Laurens, Y Huang, C Yu, TCS Martin, CA Rodriguez, ... EBioMedicine 96, 2023 | 23 | 2023 |
| Rapid treatment initiation for hepatitis C in young people who inject drugs: the seek, test, and rapid treatment randomized trial B Eckhardt, SN Kapadia, P Mateu-Gelabert, M Pai, C Fong, ... Open Forum Infectious Diseases 9 (7), ofac225, 2022 | 22 | 2022 |
| Rapid treatment initiation for hepatitis C virus infection: potential benefits, current limitations, and real-world examples AK Finbråten, BJ Eckhardt, SN Kapadia, KM Marks Gastroenterology & Hepatology 18 (11), 628, 2022 | 16 | 2022 |
| Hepatitis C testing and treatment uptake among young people who use opioids in New York city: a cross‐sectional study SN Kapadia, C Katzman, C Fong, BJ Eckhardt, H Guarino, ... Journal of viral hepatitis 28 (2), 326-333, 2021 | 16 | 2021 |
